StockData
CLCSOTCPharmaceutical PreparationsFiscal year ends December 31

Cell Source, Inc.

Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 14, 2026
$0.49−0.00 (-0.01%)

Close on Oct 19, 2026

Market cap
$21.99M
P/E (TTM)
–
Dividend yield
–

Cell Source, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Cell Source does not break out revenue by segment, region or product in the tagged data of its filings for this period type.